Mural Oncology Plc Alpha and Beta Analysis
| MURADelisted Stock | 2.04 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mural Oncology Plc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mural Oncology over a specified time horizon. Remember, high Mural Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mural Oncology's market risk premium analysis include:
Beta (0.16) | Alpha (0.02) | Risk 1.06 | Sharpe Ratio (0.10) | Expected Return (0.11) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Mural |
Mural Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mural Oncology market risk premium is the additional return an investor will receive from holding Mural Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mural Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mural Oncology's performance over market.| α | -0.02 | β | -0.16 |
Mural Oncology Fundamentals Vs Peers
Comparing Mural Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mural Oncology's direct or indirect competition across all of the common fundamentals between Mural Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mural Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mural Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mural Oncology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Mural Oncology to competition |
| Fundamentals | Mural Oncology | Peer Average |
| Return On Equity | -1.04 | -0.31 |
| Return On Asset | -0.49 | -0.14 |
| Current Valuation | (19.94 M) | 16.62 B |
| Shares Outstanding | 17.34 M | 571.82 M |
| Shares Owned By Insiders | 13.40 % | 10.09 % |
| Shares Owned By Institutions | 46.57 % | 39.21 % |
| Number Of Shares Shorted | 417.44 K | 4.71 M |
Mural Oncology Opportunities
Mural Oncology Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Is Mural Oncology plc stock attractive for growth ETFs - Bond Market Capital Efficient Trading Techniques - newser.com | 10/27/2025 |
2 | Adam Cutler Sells 7,148 Shares of Mural Oncology Stock | 11/12/2025 |
3 | Will Mural Oncology plc stock benefit from green energy trends - Entry Point AI Forecasted EntryExit Points - newser.com | 11/18/2025 |
4 | Citadel Group discloses 1.32 percent stake in Mural Oncology - Investing.com | 11/21/2025 |
5 | Mural Oncology wins Irish court nod for XOMA deal, Nasdaq trading expected to end Dec. 4 - Stock Titan | 12/03/2025 |
About Mural Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mural or other delisted stocks. Alpha measures the amount that position in Mural Oncology Plc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Mural Oncology Upcoming Company Events
As portrayed in its financial statements, the presentation of Mural Oncology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mural Oncology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mural Oncology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mural Oncology. Please utilize our Beneish M Score to check the likelihood of Mural Oncology's management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Mural Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Mural Stock
If you are still planning to invest in Mural Oncology Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mural Oncology's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |